In Vivo is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

CEO Interview: AstraZeneca's David Brennan

Executive Summary

David Brennan has sharpened AstraZeneca's therapeutic area focus and embraced external R&D. The next two years will determine whether the productivity drive is working--or if more radical change is needed.
Advertisement

Related Content

AZ Joins Spin-Out Set, Forms GI Play Albireo
Can Amgen Find a New Engine?
Reviewing Five Years of Big Pharma's Biotech Acquisitions
Reviewing Five Years of Big Pharma's Biotech Acquisitions
Co-Promotes: A Marketplace Reality, But Do They Make Sense?
CEO Interview: Novartis' Dan Vasella
Pfizer Gets Closer to Customers
BMS Deals Diabetes Drugs, Solidifies Specialist Stance
BMS Deals Diabetes Drugs, Solidifies Specialist Stance
Pfizer Gets Closer to Customers

Topics

Related Companies

Related Deals

Advertisement
UsernamePublicRestriction

Register

IV002909

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel